Brief: Xilio Promotes Katarina Luptakova To Chief Medical Officer And Scott Coleman To Chief Development Officer
05/09/2023 13:53
Sept 5 (Reuters) - Xilio Therapeutics Inc XLO.O :
* XILIO THERAPEUTICS ANNOUNCES PROMOTION OF KATARINA
LUPTAKOVA,
M.D., TO CHIEF MEDICAL OFFICER AND SCOTT COLEMAN, PH.D., TO
CHIEF DEVELOPMENT OFFICER
Source text for Eikon: ID:nGNX5xQ7B2
Further company coverage: XLO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Xilio Therapeutics
See all newsXilio Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Xilio Therapeutics Inc expected to post a loss of 92 cents a share - Earnings Preview
Brief: Xilio Therapeutics Reports Second Quarter 2026 Financial Results And Provides Pipeline And Business Updates
U.S. STOCKS ON THE MOVE-Palantir, AeroVironment, Valvoline
U.S. STOCKS ON THE MOVE-Medtronic, AeroVironment, Tesla